RT-88
|
Arrhythmias and health economics
|
|
|
Nina Rehnqvist, Göran Engholm,
Lars Nyberg.
The National Board of Health and Welfare, Stockholm, Sweden
|
|
Abstract
|
|
The consumption of resources due to rhythm disorders
in Sweden is beeing described. Rhythm disorders are not uncommon but do not lay a heavy
burden on health economics. Drug costs for some drugs with antiarrhythmic actions are
increasing in a noticeable way. Pacemaker treatment is fairly constant and admissions for
rhythm disorders or conduction disorders are beeing reduced. Drug sales due to disorders
in the heart and circulatory system constitute 14% of all drug sale costs whereas hospital
costs for arrhythmias are in the order of less than 1%..
|
Key Words
|
|
Cardiac arrhythmias - epidemiology
health economics, Sweden, drug costs, pacemakers, cardiac operations, ICD, R
|
